Avalo Therapeutics, Inc. (NASDAQ:AVTX) Major Shareholder Caissa Capital Management Ltd. Buys 3,000 Shares

Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. acquired 3,000 shares of the firm’s stock in a transaction that occurred on Friday, June 16th. The stock was purchased at an average cost of $3.90 per share, for a total transaction of $11,700.00. Following the completion of the purchase, the insider […]

Related Keywords

,Armistice Capital ,Great Point Partners ,Avalo Therapeutics Company Profile ,Alyeska Investment Group ,Nasdaq ,Renaissance Technologies ,Avalo Therapeutics Inc ,Caissa Capital Management Ltd ,Millennium Management ,Avalo Therapeutics ,Get Rating ,Caissa Capital Management ,Capital Management ,Point Partners ,Avalo Therapeutics Daily ,Nasdaq Avtx ,Avtx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,